Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6
Pharmacology Research and Perspectives, 2020, 8, e00649
Similar Articles
Quick Tips
This is an overview of where and by who this paper has been cited.
Help Us
Non-profit projects normally ask for donations. We don't. We will survive one way or another. If you wish to help us, please spread the word to let more people use this service.
It is delightful to see our efforts are useful to a broad range of researchers.